引用本文:Wang Yueting1,Zhang Xin2,Zhao Jing1.抑制大鼠脑缺血再灌注损伤中GSK-3β活性对自噬的影响及可能机制[J].中华医学教育探索杂志,2019,18(5):551-
抑制大鼠脑缺血再灌注损伤中GSK-3β活性对自噬的影响及可能机制
Influence of glycogen synthase kinase-3β inhibition on autophagy in rats with cerebral ischemia/reperfusion injury and possible mechanism
DOI:
中文关键词:  自噬  糖原合成酶激酶-3β  酵母自噬启动ATG1激酶同源蛋白  脑缺血再灌注损伤
英文关键词:autophagy  glycogen synthase kinase-3β  Unc-51 like autophagy activating kinase 1  cerebral ischemia/reperfu-sion injury
基金项目:
作者单位
Wang Yueting1,Zhang Xin2,Zhao Jing1 1. 重庆医科大学基础医学院病理生理学教研室重庆 4000162. 重庆医科大学第二附属医院全科重庆 400010 
摘要点击次数: 1706
全文下载次数: 771
中文摘要:
      目的:探讨大鼠缺血再灌注损伤中抑制糖原合成酶激酶3β(glycogen synthase kinase 3β,GSK-3β)后对自噬的影响及如何通过酵母自噬启动ATG1激酶同源蛋白(Unc-51 like autophagy activating kinase 1,ULK1)影响自噬的机制。方法:实验选取SD大鼠为研究对象,分为假手术组(Sham 组,仅结扎颈内动脉)、缺血再灌注组(MCAO 组,大脑中动脉栓塞术制备局灶脑缺血再灌注模型)、GSK-3β干扰片段组(siGSK-3β组,建模前24 h注射GSK-3β干扰片段)、GSK-3β无意义序列组(ConsiGSK-3β组,建模前24 h注射无意义序列)、GSK-3β抑制剂组(SB216763组,建模前6 h注射抑制剂SB216763),每组5只。免疫印迹检测大脑皮质酪氨酸216号位点磷酸化GSK-3β[GSK-3β(P-tyr216)]、自噬相关蛋白轻链3抗体Ⅰ/Ⅱ(autophagy microtubule-as-sociated protein light chain 3 antibodyⅠ/Ⅱ,LC3BⅠ/Ⅱ)、泛素结合蛋白(sequestosome 1,P62)、磷酸化ULK1(phosphorylated ULK1,P-ULK1)、乙酰化ULK1(acetylated ULK1,AcK)的表达,电镜显示自噬体数量。结果:与Sham组比较,MCAO组中GSK-3β(P-tyr216)增高(P=0.000)。siGSK-3β、SB216763组相较MCAO组,LC3BⅡ/LC3BⅠ升高(P=0.000)、P62表达下降(P=0.000)、P-ULK1表达增高(P=0.000)、AcK表达下降(SB216763:P<0.05;siGSK-3β:P<0.01),电镜可见自噬小体。结论:在脑缺血再灌注损伤中,GSK-3β活性抑制后可通过磷酸化ULK1增强细胞自噬。
英文摘要:
      Objective:To investigate the influence of glycogen synthase kinase-3β(GSK-3β) inhibition on autophagy in rats with cere-bral ischemia/reperfusion injury and the mechanism of affecting autophagy via Unc-51 like autophagy activating kinase 1(ULK1). Methods:Sprague-Dawley rats were divided into sham-operation group(Sham group,ligation of the internal carotid artery alone),middle cerebral artery occlusion(MCAO) group(MCAO was performed to establish a model of focal cerebral ischemia/reperfusion),GSK-3β interference fragment group(siGSK-3β group;the GSK-3β interference fragment was injected at 24 hours before model establishment),GSK-3β non-significant sequence group(ConsiGSK-3β group;non-significant sequence was injected at 24 hours before model establishment),and GSK-3β inhibitor group(SB216763 group;the inhibitor SB216763 was injected at 6 hours before model establishment),with 5 rats in each group. Western blotting was used to measure the expression of tyrosine-216-phosphorylated GSK-3β [GSK-3β(P-tyr216)],autophagy microtubule-associated protein light chain 3 antibody Ⅰ/Ⅱ(LC3B Ⅰ/Ⅱ),sequestosome 1(P62),phosphorylated ULK1(P-ULK1),and acetylated ULK1 (AcK) in the cerebral cortex. An electron microscope was used to measure the number of autophagosomes. Results:Compared with the Sham group,the MCAO group had a significant increase in the expression of GSK-3β(P-tyr216)(P=0.000). Compared with the MCAO group,the siGSK-3β group and the SB216763 group had significant increases in the expression of LC3B I/II and P-ULK1(P=0.000) and significant reductions in the expression of P62(P=0.000) and AcK(SB216763 group:P<0.05;siGSK-3β group:P<0.01),and autophagosomes were observed under the electron microscope. Conclusion:GSK-3β inhibition can enhance au-tophagy via phosphorylated ULK1 in cerebral ischemia/reperfu-sion injury.
查看全文  查看/发表评论  下载PDF阅读器
关闭
微信关注二维码